Frenkel Sally R, Simon Jordan, Alexander Harold, Dennis Michael, Ricci John L
Department of Orthopaedic Surgery, Musculoskeletal Research Center, New York University Hospital for Joint Diseases, New York, New York 10003, USA.
J Biomed Mater Res. 2002;63(6):706-13. doi: 10.1002/jbm.10408.
Orthopedic implants often loosen due to the invasion of fibrous tissue. The aim of this study was to devise a novel implant surface that would speed healing adjacent to the surface, and create a stable interface for bone integration, by using a chemoattractant for bone precursor cells, and by controlling tissue migration at implant surfaces via specific surface microgeometry design. Experimental surfaces were tested in a canine implantable chamber that simulates the intramedullary bone response around total joint implants. Titanium and alloy surfaces were prepared with specific microgeometries, designed to optimize tissue attachment and control fibrous encapsulation. TGF beta, a mitogen and chemoattractant (Hunziker EB, Rosenberg LC. J Bone Joint Surg Am 1996;78:721-733) for osteoprogenitor cells, was used to recruit progenitor cells to the implant surface and to enhance their proliferation. Calcium sulfate hemihydrate (CS) was the delivery vehicle for TGF beta; CS resorbs rapidly and appears to be osteoconductive. Animals were sacrificed at 6 and 12 weeks postoperatively. Results indicated that TGFbeta can be reliably released in an active form from a calcium sulfate carrier in vivo. The growth factor had a significant effect on bone ingrowth into implant channels at an early time period, although this effect was not seen with higher doses at later periods. Adjustment of dosage should render TGF beta more potent at later time periods. Calcium sulfate treatment without TGF beta resulted in a significant increase in bone ingrowth throughout the 12-week time period studied. Bone response to the microgrooved surfaces was dramatic, causing greater ingrowth in 9 of the 12 experimental conditions. Microgrooves also enhanced the mechanical strength of CS-coated specimens. The grooved surface was able to control the direction of ingrowth. This surface treatment may result in a clinically valuable implant design to induce rapid ingrowth and a strong bone-implant interface, contributing to implant longevity.
骨科植入物常常因纤维组织的侵入而松动。本研究的目的是设计一种新型植入物表面,通过使用骨前体细胞的化学引诱剂,并通过特定的表面微观几何设计来控制植入物表面的组织迁移,从而加速与表面相邻部位的愈合,并为骨整合创建一个稳定的界面。在一个模拟全关节植入物周围髓内骨反应的犬类可植入腔室中对实验表面进行测试。制备具有特定微观几何形状的钛和合金表面,旨在优化组织附着并控制纤维包囊形成。转化生长因子β(TGF-β)是一种对骨祖细胞有促有丝分裂作用和化学引诱作用的物质(洪齐克·E·B,罗森伯格·L·C。《美国骨与关节外科杂志》1996年;78:721 - 733),用于将祖细胞募集到植入物表面并增强其增殖。半水硫酸钙(CS)是TGF-β的递送载体;CS吸收迅速,似乎具有骨传导性。在术后6周和12周处死动物。结果表明,TGF-β在体内能以活性形式从硫酸钙载体中可靠释放。生长因子在早期对骨长入植入通道有显著影响,尽管在后期高剂量时未观察到这种效果。调整剂量应使TGF-β在后期更有效。在整个12周的研究时间段内,未添加TGF-β的硫酸钙处理导致骨长入显著增加。骨对微槽表面的反应显著,在12种实验条件中的9种条件下导致更大的长入。微槽还增强了涂有CS的标本的机械强度。有槽表面能够控制长入方向。这种表面处理可能会产生一种临床上有价值的植入物设计,以诱导快速长入和形成牢固的骨 - 植入物界面,从而延长植入物的使用寿命。